EMA has published a draft reflection paper
outlining the current thinking on the use of artificial intelligence
(AI) to support the safe and effective development, regulation and use
of human and veterinary medicines. This paper, which is now open for
public consultation, reflects on principles relevant to the application
of AI and machine learning (ML) at any step of a medicines’ lifecycle,
from drug discovery to the post-authorisation setting. (...)
Canada’s new sanctioned property reporting obligations in force
-
To read this post, please log in at https://globalsanctions.com. Not a
member? Join at https://globalsanctions.com/subscribe.
8 ore fa
Post
Nessun commento:
Posta un commento